Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Ovis aries | Cyclooxygenase-2 | Starlite/ChEMBL | References |
Ovis aries | Cyclooxygenase-1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0045 | 0.2033 | 0.5 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0062 | 0.3968 | 0.5227 |
Schistosoma mansoni | peroxidasin | 0.0095 | 0.7593 | 1 |
Onchocerca volvulus | 0.0095 | 0.7593 | 0.5 | |
Chlamydia trachomatis | glutamine binding protein | 0.0045 | 0.2033 | 0.5 |
Onchocerca volvulus | Peroxidase homolog | 0.0095 | 0.7593 | 0.5 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein (hisJ) | 0.0045 | 0.2033 | 0.5 |
Onchocerca volvulus | 0.0095 | 0.7593 | 0.5 | |
Echinococcus multilocularis | peroxidasin | 0.0095 | 0.7593 | 1 |
Echinococcus granulosus | peroxidasin | 0.0095 | 0.7593 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0117 | 1 | 1 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0062 | 0.3968 | 0.5227 |
Onchocerca volvulus | Peroxidasin homolog | 0.0095 | 0.7593 | 0.5 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein | 0.0045 | 0.2033 | 0.5 |
Onchocerca volvulus | Peroxidase homolog | 0.0095 | 0.7593 | 0.5 |
Schistosoma mansoni | peroxidasin | 0.0095 | 0.7593 | 1 |
Mycobacterium tuberculosis | Probable glutamine-binding lipoprotein GlnH (GLNBP) | 0.0045 | 0.2033 | 0.5 |
Onchocerca volvulus | Peroxidasin homolog | 0.0095 | 0.7593 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0117 | 1 | 1 |
Onchocerca volvulus | Dual oxidase homolog | 0.0095 | 0.7593 | 0.5 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0062 | 0.3968 | 0.5227 |
Mycobacterium ulcerans | glutamine-binding lipoprotein GlnH | 0.0045 | 0.2033 | 0.5 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.0095 | 0.7593 | 0.5 |
Onchocerca volvulus | 0.0095 | 0.7593 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.